Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Echinococcosis and other parasitic infections in domestic dogs from urban areas of an Argentinean Patagonian city.

Flores V, Viozzi G, Garibotti G, Zacharias D, Debiaggi MF, Kabaradjian S.

Medicina (B Aires). 2017;77(6):469-474.

2.

Genetic characterization of human hydatid cysts shows coinfection by Echinococcus canadensis G7 and Echinococcus granulosus sensu stricto G1 in Argentina.

Debiaggi MF, Soriano SV, Pierangeli NB, Lazzarini LE, Pianciola LA, Mazzeo ML, Moguillansky S, Farjat JAB.

Parasitol Res. 2017 Sep;116(9):2599-2604. doi: 10.1007/s00436-017-5555-2. Epub 2017 Jul 18.

PMID:
28721526
3.

First study about the development of adult Echinococcus canadensis G6 genotype of goat origin in experimentally infected dogs.

Soriano SV, Debiaggi MF, Pierangeli NB, Pianciola LA, Bergagna HFJ, Lazzarini LE, Mazzeo ML, Basualdo JA.

Vet Parasitol. 2016 Sep 15;228:6-12. doi: 10.1016/j.vetpar.2016.08.008. Epub 2016 Aug 6.

PMID:
27692331
4.

Emergence of a VIM-1 MBL and CTX-M-15 ESbL-producing Klebsiella pneumoniae clone from acute and rehabilitation hospitals in Italy.

Nucleo E, Spalla M, Piazza A, Caltagirone MS, Asticcioli S, Debiaggi M, Matti C, Daturi R, Navarra A, Labonia M, Migliavacca R.

New Microbiol. 2013 Jul;36(3):279-82. Epub 2013 Jun 30. Erratum in: New Microbiol. 2013 Oct;36(4):435.

5.

The optimum cut-off value to differentiate Echinococcus granulosus sensu stricto from other species of E. granulosus sensu lato using larval rostellar hook morphometry.

Soriano SV, Pierangeli NB, Pianciola LA, Mazzeo M, Lazzarini LE, Debiaggi MF, Bergagna HF, Basualdo JA.

J Helminthol. 2015 Jan;89(1):1-8. doi: 10.1017/S0022149X13000473. Epub 2013 Jul 10.

PMID:
23842071
6.

Infection and coinfection of human rhinovirus C in stem cell transplant recipients.

Canducci F, Debiaggi M, Ceresola ER, Sampaolo M, Alessandrino EP, Brerra R, Piazza A, Clementi M.

Clin Dev Immunol. 2013;2013:236081. doi: 10.1155/2013/236081. Epub 2013 Feb 27.

7.

The role of infections and coinfections with newly identified and emerging respiratory viruses in children.

Debiaggi M, Canducci F, Ceresola ER, Clementi M.

Virol J. 2012 Oct 27;9:247. doi: 10.1186/1743-422X-9-247. Review.

8.

Epidemiological, molecular and clinical features of enterovirus 109 infection in children and in adult stem cell transplant recipients.

Debiaggi M, Ceresola ER, Sampaolo M, Alessandrino EP, Brerra R, Piazza A, Clementi M, Canducci F.

Virol J. 2012 Sep 4;9:183. doi: 10.1186/1743-422X-9-183.

9.

Influence of lingual bracket position on microbial and periodontal parameters in vivo.

Sfondrini MF, Debiaggi M, Zara F, Brerra R, Comelli M, Bianchi M, Pollone SR, Scribante A.

J Appl Oral Sci. 2012 May-Jun;20(3):357-61.

10.

Differences in biofilm formation and aggregative adherence between beta-lactam susceptible and beta-lactamases producing P. mirabilis clinical isolates.

Nucleo E, Fugazza G, Migliavacca R, Spalla M, Comelli M, Pagani L, Debiaggi M.

New Microbiol. 2010 Jan;33(1):37-45.

11.

Molecular epidemiology of KI and WU polyomaviruses in infants with acute respiratory disease and in adult hematopoietic stem cell transplant recipients.

Debiaggi M, Canducci F, Brerra R, Sampaolo M, Marinozzi MC, Parea M, Arghittu M, Alessandrino EP, Nava S, Nucleo E, Romero E, Clementi M.

J Med Virol. 2010 Jan;82(1):153-6. doi: 10.1002/jmv.21659.

PMID:
19950241
12.

Two-year prospective study of single infections and co-infections by respiratory syncytial virus and viruses identified recently in infants with acute respiratory disease.

Canducci F, Debiaggi M, Sampaolo M, Marinozzi MC, Berrè S, Terulla C, Gargantini G, Cambieri P, Romero E, Clementi M.

J Med Virol. 2008 Apr;80(4):716-23. doi: 10.1002/jmv.21108.

PMID:
18297694
13.

Long-term study on symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients.

Debiaggi M, Canducci F, Terulla C, Sampaolo M, Marinozzi MC, Alessandrino PE, Colombo AA, Caldera D, Bragotti LZ, Migliavacca R, Bianchi E, Romero E, Clementi M.

New Microbiol. 2007 Jul;30(3):255-8.

14.

Severe recurrent myelitis in patients with hepatitis C virus infection.

Aktipi KM, Ravaglia S, Ceroni M, Nemni R, Debiaggi M, Bastianello S, Alfonsi E, Zardini E, Minoli L, Tavazzi E, Marchioni E.

Neurology. 2007 Feb 6;68(6):468-9. No abstract available.

PMID:
17283325
15.

Persistent symptomless human metapneumovirus infection in hematopoietic stem cell transplant recipients.

Debiaggi M, Canducci F, Sampaolo M, Marinozzi MC, Parea M, Terulla C, Colombo AA, Alessandrino EP, Bragotti LZ, Arghittu M, Goglio A, Migliavacca R, Romero E, Clementi M.

J Infect Dis. 2006 Aug 15;194(4):474-8. Epub 2006 Jul 12.

PMID:
16845630
16.

Distinct mutational drug resistance profiles of HIV-1 RNA in plasma and culture isolates of patients receiving antiretroviral therapy.

Debiaggi M, Bruno R, Sacchi P, Achilli G, Romero E, Filice G.

Intervirology. 2002;45(1):52-5.

PMID:
11937771
17.

A promising cultural-biomolecular method for rapid isolation and identification of mycobacteria.

Debiaggi M, Zara F, Brerra R, Achilli G, Romero E, Filice G.

Clin Microbiol Infect. 1999 Mar;5(3):170-173. No abstract available.

18.

Quantitative assessment of cell-associated and cell-free virus in cervicovaginal samples of HIV-1-infected women.

Debiaggi M, Spinillo A, Zara F, Santolo A, Brerra R, Maserati R, Romero E, Filice G.

Clin Microbiol Infect. 1999 Oct;5(10):605-11. doi: 10.1111/j.1469-0691.1999.tb00416.x.

19.

Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions.

Spinillo A, Debiaggi M, Zara F, Maserati R, Polatti F, De Santolo A.

BJOG. 2001 Jun;108(6):634-41.

20.

Human immunodeficiency virus type 1-related nucleic acids and papillomavirus DNA in cervicovaginal secretions of immunodeficiency virus-infected women.

Spinillo A, Debiaggi M, Zara F, De Santolo A, Polatti F, Filice G.

Obstet Gynecol. 2001 Jun;97(6):999-1004.

PMID:
11384710
21.

Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.

Debiaggi M, Zara F, Spinillo A, De Santolo A, Maserati R, Bruno R, Sacchi P, Achilli G, Pistorio A, Romero E, Filice G.

Eur J Clin Microbiol Infect Dis. 2001 Feb;20(2):91-6.

PMID:
11305478
22.

Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy.

Debiaggi M, Zara F, Pistorio A, Bruno R, Sacchi P, Patruno SF, Achilli G, Romero E, Filice G.

Int J Infect Dis. 2000;4(4):187-93.

23.

Transfusion-transmitted virus infection in HIV-1-seropositive patients.

Debiaggi M, Zara F, Sacchi P, Bruno R, Mazzucco M, Poma R, Raffaldi F, Gerace L, Perini M, Pistorio A, Romero E, Filice G.

Clin Microbiol Infect. 2000 May;6(5):246-50.

24.

Dominant role of host selective pressure in driving hepatitis C virus evolution in perinatal infection.

Manzin A, Solforosi L, Debiaggi M, Zara F, Tanzi E, RomanĂ² L, Zanetti AR, Clementi M.

J Virol. 2000 May;74(9):4327-34.

25.

Prevalence and histologic features of transfusion transmitted virus and hepatitis C virus coinfection in a group of HIV patients.

Bruno R, Sacchi P, Debiaggi M, Patruno SF, Zara F, Ciappina V, Brunetti E, Filice C, Zocchetti C, Maffezzini E, Pistorio A, Filice G.

Dig Liver Dis. 2000 Oct;32(7):617-20.

PMID:
11142562
26.

HIV type 1 intraperitoneal infection of rabbits permits early detection of serum antibodies to Gag, Pol, and Env proteins, neutralizing antibodies, and proviral DNA from peripheral blood mononuclear cells.

Debiaggi M, Bruno R, Carlevari M, Achilli G, Emanuelli B, Cereda PM, Romero E, Filice G.

AIDS Res Hum Retroviruses. 1995 Feb;11(2):287-96.

PMID:
7742042
27.

Booster PCR: evaluation of an improved method for amplification of a few HIV-1 proviral DNA sequences.

Filice G, Debiaggi M, Cereda PM, Romero E.

New Microbiol. 1993 Apr;16(2):129-33.

PMID:
8510566
28.

Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users.

Filice G, Patruno S, Campisi D, Chiesa A, Orsolini P, Debiaggi M, Bruno R, Tinelli M.

New Microbiol. 1993 Jan;16(1):35-42.

PMID:
7682283
29.

Immunoblot typing of oxacillin-resistant Staphylococcus aureus clinical isolates.

Pagani L, Debiaggi M, Garbagnoli P, Romero E.

J Chemother. 1991 Jan;3 Suppl 1:172-5.

PMID:
12041758
30.

Effects of propolis flavonoids on virus infectivity and replication.

Debiaggi M, Tateo F, Pagani L, Luini M, Romero E.

Microbiologica. 1990 Jul;13(3):207-13.

PMID:
2125682
31.

Emergence of cross-resistance to imipenem and other beta-lactam antibiotics in Pseudomonas aeruginosa during therapy.

Pagani L, Landini P, Luzzaro F, Debiaggi M, Romero E.

Microbiologica. 1990 Jan;13(1):43-53.

PMID:
2155376
32.

Modification of norfloxacin inhibition of DNA gyrase induced by a 28 KDal DNA binding protein.

Landini P, Pagani L, Debiaggi M, Cereda PM, Romero E.

Microbiologica. 1989 Jul;12(3):247-55.

PMID:
2550742
33.

Norfloxacin resistance in Providencia stuartii: modifications in DNA-gyrase and permeability.

Landini P, Pagani L, Cereda PM, Debiaggi M, Romero E.

Biochem Pharmacol. 1988 May 1;37(9):1855-6. No abstract available.

PMID:
2837244
34.

Antiviral activity of Chamaecyparis lawsoniana extract: study with herpes simplex virus type 2.

Debiaggi M, Pagani L, Cereda PM, Landini P, Romero E.

Microbiologica. 1988 Jan;11(1):55-61.

PMID:
2832710
35.

Beta-lactam resistant Pseudomonas aeruginosa strains emerging during therapy: synergistic resistance mechanisms.

Pagani L, Debiaggi M, Tenni R, Cereda PM, Landini P, Romero E.

Microbiologica. 1988 Jan;11(1):47-53.

PMID:
2832709
36.

Preliminary characterization of an inhibitory activity of fetal bovine serum on the infectivity of rotavirus strain SA-11.

Debiaggi M, Cereda PM, Pagani L, Romero E.

Microbiologica. 1987 Jul;10(3):257-63.

PMID:
3041181
37.

Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy.

Pagani L, Scarabelli M, Cereda PM, Debiaggi M.

Microbiologica. 1987 Jan;10(1):103-10.

PMID:
3106759
38.

Third-generation cephalosporins resistance in clinical isolates of Enterobacteriaceae.

Perduca M, Pagani L, Cereda PM, Debiaggi M.

Microbiologica. 1986 Apr;9(2):199-207.

PMID:
3487023
39.

Serum inhibitor of coronaviruses OC43 and NCDCV: a study in vivo.

Debiaggi M, Luini M, Cereda PM, Perduca M, Romero E.

Microbiologica. 1986 Jan;9(1):33-7.

PMID:
3005805
40.

Coronavirus inhibitor in human sera: age distribution and prevalence.

Debiaggi M, Perduca M, Cereda PM, Romero E.

Microbiologica. 1986 Jan;9(1):109-12.

PMID:
3005804
41.

Phosphatidyl-serine inhibition of OC43 and NCDCV coronavirus infectivity.

Debiaggi M, Perduca M, Romero E, Cereda PM.

Microbiologica. 1985 Oct;8(4):313-7.

PMID:
4069011
42.

Herpes simplex virus infection in patients affected by dental caries.

Cereda PM, Debiaggi M, Perduca M.

Microbiologica. 1985 Jul;8(3):289-91.

PMID:
2993827
43.

Bovine leukemia virus inhibiting activity in fetal calf serum.

Cereda PM, Debiaggi M, Mignatti P, Pagani L, Romero E.

Microbiologica. 1984 Jul;7(3):251-6.

PMID:
6094986
44.

Antibody to bovine leukemia virus in sera from leukemic patients.

Cereda PM, Debiaggi M, Romero E.

Microbiologica. 1984 Jan;7(1):107-12.

PMID:
6328223

Supplemental Content

Loading ...
Support Center